Edwards Lifesciences Corp financial data

Symbol
EW on NYSE
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Location
One Edwards Way, Irvine, California
State of incorporation
Delaware
Fiscal year end
December 31
Former names
CVG CONTROLLED INC (to 1/21/2000)
Latest financial report
Q1 2024 - Apr 29, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 339 % +2.92%
Quick Ratio 93.3 % +13.3%
Debt-to-equity 38.8 % -6.91%
Return On Equity 20.9 %
Return On Assets 15.1 %
Operating Margin 25 % -19.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 603M shares -0.6%
Common Stock, Shares, Outstanding 602M shares -0.59%
Entity Public Float 56.8B USD -2.74%
Common Stock, Value, Issued 652M USD +0.73%
Weighted Average Number of Shares Outstanding, Basic 602M shares -0.97%
Weighted Average Number of Shares Outstanding, Diluted 604M shares -1.11%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 6.14B USD +11.7%
Research and Development Expense 1.1B USD +12.1%
Operating Income (Loss) 1.53B USD -9.71%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 1.61B USD -7%
Income Tax Expense (Benefit) 199M USD -17.5%
Net Income (Loss) Attributable to Parent 1.41B USD +3.35%
Earnings Per Share, Basic 2.33 USD/shares -3.72%
Earnings Per Share, Diluted 2.32 USD/shares -3.73%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.22B USD +40.4%
Accounts Receivable, after Allowance for Credit Loss, Current 818M USD +13.9%
Inventory, Net 1.21B USD +32%
Other Assets, Current 251M USD +31.7%
Assets, Current 4.17B USD +28%
Deferred Income Tax Assets, Net 777M USD +42.8%
Property, Plant and Equipment, Net 1.77B USD +7.41%
Operating Lease, Right-of-Use Asset 98.4M USD +11.2%
Intangible Assets, Net (Excluding Goodwill) 447M USD 0%
Goodwill 1.25B USD -4.25%
Other Assets, Noncurrent 768M USD +161%
Assets 9.74B USD +12.5%
Accounts Payable, Current 212M USD +17.4%
Employee-related Liabilities, Current 237M USD +5.05%
Liabilities, Current 1.11B USD +2.66%
Operating Lease, Liability, Noncurrent 77.2M USD +16.6%
Other Liabilities, Noncurrent 267M USD +2.46%
Liabilities 2.55B USD -1.52%
Accumulated Other Comprehensive Income (Loss), Net of Tax -233M USD +8.65%
Retained Earnings (Accumulated Deficit) 9.34B USD +17.8%
Stockholders' Equity Attributable to Parent 7.12B USD +19.1%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 7.19B USD +18.5%
Liabilities and Equity 9.74B USD +12.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -53.5M USD -117%
Net Cash Provided by (Used in) Financing Activities 61.7M USD
Net Cash Provided by (Used in) Investing Activities 63.1M USD +12520%
Common Stock, Shares Authorized 1.05B shares 0%
Common Stock, Shares, Issued 652M shares +0.73%
Common Stock, Par or Stated Value Per Share 1 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 81M USD -22%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.23B USD +40.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 19.9M USD +3.11%
Deferred Tax Assets, Valuation Allowance 90.2M USD -8.98%
Deferred Tax Assets, Gross 958M USD +37.6%
Operating Lease, Liability 97.9M USD +3.05%
Depreciation 139M USD +3.73%
Payments to Acquire Property, Plant, and Equipment 65.3M USD +6.18%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 1.44B USD +1.12%
Lessee, Operating Lease, Liability, to be Paid 106M USD +3.02%
Property, Plant and Equipment, Gross 2.61B USD +9.38%
Operating Lease, Liability, Current 24.8M USD -1.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 19.6M USD +5.95%
Lessee, Operating Lease, Liability, to be Paid, Year One 26.8M USD -0.74%
Deferred Income Tax Expense (Benefit) -262M USD -4.42%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 7.9M USD +2.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 16.3M USD +30.4%
Deferred Tax Assets, Operating Loss Carryforwards 75.9M USD +5.86%
Deferred Federal Income Tax Expense (Benefit) -188M USD +0.11%
Current Income Tax Expense (Benefit) 461M USD -7.19%
Preferred Stock, Shares Authorized 50M shares 0%
Unrecognized Tax Benefits 609M USD +22.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 12.9M USD +22.9%
Operating Lease, Payments 8.2M USD +15.5%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 58.1M USD -4.13%
Current Federal Tax Expense (Benefit) 317M USD -14%
Amortization of Intangible Assets 6.1M USD +7.02%
Depreciation, Depletion and Amortization 38.5M USD +9.38%
Share-based Payment Arrangement, Expense 145M USD +8.85%
Deferred State and Local Income Tax Expense (Benefit) -54.2M USD +7.98%
Interest Expense 17.6M USD -8.33%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%